Sigmapharm Laboratories Trademark Details
| Word Mark | Sigmapharm Laboratories |
|---|---|
| Status | Alive 731 — Second Extension - Granted |
Current Owner
| Serial Number | 77712521 |
|---|---|
| Status Date | Thursday, July 14, 2016 |
| Filing Date | Thursday, July 14, 2016 |
| Attorney | Inna Fayenson |
Correspondent
SUSAN M SCHLESINGER
MEISTER SEELIG & FEIN LLP
140 EAST 45TH STREET 19TH FLOOR
NEW YORK, NY 10017-5684
MEISTER SEELIG & FEIN LLP
140 EAST 45TH STREET 19TH FLOOR
NEW YORK, NY 10017-5684
Case File Statements
| Indication of Colors | Color is not claimed as a feature of the mark. |
|---|---|
| Disclaimer with Predetermined Text | "Laboratories" |
| Description of Mark | The mark consists of two circles, one within the other. The circles do not intersect. Portions of the circles are intersected perpendicularly by a straight line. A straight line protrudes outward to the left at the top of the largest circle. The words "SigmaPharm Laboratories" are depicted directly beneath the circles. The logo depicts the Greek character "phi" inside the Greek character "sigma". |
| Goods & Services | Pharmaceutical preparations, namely, a drug delivery system comprising solid dosage delivery agents and a wide variety of therapeutic agents in molecular or amorphous state, in the form of tablets, capsules and powder dosage forms, prepared using company's patented technology platforms which will result into more bioavailable and stable dosage forms of therapeutic agents for the treatment of hypertension, hypercholesterolemia, depression, atherosclerosis, thyroid deficiency syndrome, organ rejection, hepatitis and, HIV and fungal infections |
| Pseudo Mark | Sigma Pharm Laboratories; Sigma Pharmaceutical Laboratories |
Classifications
| International Class Codes |
005
|
|---|---|
| U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
| Status | 6 — Active |
| Status Date | Thursday, December 31, 2009 |
| Primary Code | 005 |